How does leuprolide therapy affect metabolic parameters, including glucose metabolism and lipid profiles, and what are the risks for developing metabolic syndrome during treatment?
Gaurav ChauhanContributor
How does leuprolide therapy affect metabolic parameters such as glucose and lipid levels?
Share
Leuprolide, used in hormone-sensitive conditions like prostate cancer, can disrupt insulin sensitivity and lipid metabolism, potentially increasing the risk of metabolic syndrome.
Leuprolide therapy can increase the risk of insulin resistance and altered lipid profiles, potentially leading to metabolic syndrome. Monitor glucose and lipid levels regularly.